One of the most anticipated deals in the healthcare space appears to have been put on the backburner for now, with the promoter having second thoughts about putting this venture on the block. What led to the pullback? Valuations aside, there is also buzz of a former shareholder throwing his hat in the ring, with funds from private equity and other backers to buy out the company. Considering the acrimonious past involving the two parties, perhaps this is one face-off they didn’t want. It would have been sweet revenge for the bidder, but alas, it’s not happening at least for now, based on the grapevine.